Zimbabwe’s draft amendment to Statutory Instrument 330 of 2000, which would prohibit medical‑aid societies from owning or operating health‑care facilities, has ignited a heated debate in Parliament. Industry representatives warn that the change could raise health‑care costs, limit access and threaten the viability of private medical‑aid schemes that currently cover less than 10 % of the population.
The amendment targets “vertical integration,” the practice of medical‑aid societies also running clinics, pharmacies or hospitals. Lawmakers argue the measure is needed to eliminate conflicts of interest, while critics contend it could destabilise an already fragile sector.
Speaking to the Parliamentary Portfolio Committee on Health, Thando Kembo, chief operating officer of Cimas Health Group, framed the issue as one of public interest. “This is not about institutions. It is about access, affordability, and the rights of ordinary Zimbabweans to health‑care,” she told legislators. Kembo noted that medical‑aid societies are voluntary groups that pool members’ contributions to obtain care in a system where public services are overstretched and private treatment is often unaffordable.
Data presented to Parliament indicate that over 13 million Zimbabweans lack formal private health‑care protection. Proponents of the current model argue that vertical integration emerged as a response to systemic failures, including tariff disputes, drug shortages and limited capacity in public facilities. By owning service points, medical‑aid societies can negotiate tariffs, protect members from price spikes and maintain a stable supply of care.
A policy briefing submitted alongside industry submissions warns of a “collapse cascade” if the amendment is enacted. The scenario outlines uncontrolled provider pricing, rising subscription fees, declining membership and eventual failure of medical‑aid schemes. Projections suggest tariffs could increase by up to 800 % in a deregulated environment.
Medical‑aid contributions average US$55‑$65 per member per month, yet utilisation rates exceed recommended levels and claims ratios often surpass 90 %. Zimbabwe is already among the most expensive health‑care destinations in the region, prompting many patients to seek treatment abroad in South Africa, Zambia or India.
Stakeholders argue that banning vertically integrated models would undermine Zimbabwe’s commitment to universal health coverage by removing one of the few mechanisms that help control costs and expand access. “Removing society‑owned facilities does not fix tariff inflation. It removes one of the few effective tools keeping costs in check,” Kembo said, adding that the likely outcome would be higher contributions, reduced benefits and diminished access for low‑income earners.
Industry players are urging Parliament to adopt a regulatory framework that addresses conflicts of interest while preserving investment in health‑care infrastructure. They cite examples from the United States and the United Kingdom, where vertically integrated systems operate under transparency rules, tariff oversight and competition laws rather than outright prohibition.
Parliament now faces a critical decision: whether to dismantle integrated health‑care models in the name of regulation or to refine oversight mechanisms while maintaining existing structures. The choice will affect the cost and availability of health‑care for millions of Zimbabweans and could shape the country’s progress toward universal health coverage.
